PMC:7594251 / 100974-102105
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T6 | 258-265 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T7 | 317-324 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T8 | 431-438 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T9 | 562-569 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T10 | 609-616 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T11 | 870-880 | Body_part | denotes | intestinal | http://purl.org/sig/ont/fma/fma7199 |
T12 | 881-891 | Body_part | denotes | fatty acid | http://purl.org/sig/ont/fma/fma82738 |
T13 | 900-907 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T14 | 1062-1069 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T114 | 248-251 | Disease | denotes | CSP | http://purl.obolibrary.org/obo/MONDO_0005078 |
T115 | 267-270 | Disease | denotes | CSP | http://purl.obolibrary.org/obo/MONDO_0005078 |
T116 | 415-418 | Disease | denotes | CSP | http://purl.obolibrary.org/obo/MONDO_0005078 |
T117 | 780-783 | Disease | denotes | CSP | http://purl.obolibrary.org/obo/MONDO_0005078 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 256-257 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T12 | 315-316 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T13 | 422-423 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T14 | 454-455 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T15 | 491-492 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T16 | 553-561 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | labelled |
T17 | 678-683 | http://purl.obolibrary.org/obo/UBERON_0007688 | denotes | field |
T18 | 864-869 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T19 | 870-880 | http://purl.obolibrary.org/obo/UBERON_0000160 | denotes | intestinal |
T20 | 870-880 | http://www.ebi.ac.uk/efo/EFO_0000834 | denotes | intestinal |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T21306 | 108-112 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T85693 | 131-133 | Chemical | denotes | 1H | http://purl.obolibrary.org/obo/CHEBI_49637 |
T57200 | 258-265 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T43008 | 317-324 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T28259 | 394-400 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
T70946 | 431-438 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T39339 | 500-506 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
T77983 | 562-569 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T24857 | 590-592 | Chemical | denotes | 1H | http://purl.obolibrary.org/obo/CHEBI_49637 |
T79343 | 609-616 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T60641 | 688-696 | Chemical | denotes | hydrogen | http://purl.obolibrary.org/obo/CHEBI_49637 |
T37117 | 834-850 | Chemical | denotes | naphthoate ester | http://purl.obolibrary.org/obo/CHEBI_46831 |
T41675 | 834-844 | Chemical | denotes | naphthoate | http://purl.obolibrary.org/obo/CHEBI_25482 |
T79793 | 845-850 | Chemical | denotes | ester | http://purl.obolibrary.org/obo/CHEBI_35701 |
T85096 | 881-891 | Chemical | denotes | fatty acid | http://purl.obolibrary.org/obo/CHEBI_35366 |
T48890 | 887-891 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T92250 | 900-907 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T53375 | 917-926 | Chemical | denotes | ketorolac | http://purl.obolibrary.org/obo/CHEBI_6129 |
T64655 | 927-930 | Chemical | denotes | ANS | http://purl.obolibrary.org/obo/CHEBI_39708 |
T63906 | 1019-1025 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
T65279 | 1062-1069 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T23599 | 1070-1076 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1101 | 909-915 | Gene | denotes | hIFABP | Gene:2169 |
1102 | 864-869 | Species | denotes | human | Tax:9606 |
1103 | 131-133 | Chemical | denotes | 1H | |
1104 | 549-552 | Chemical | denotes | 15N | |
1105 | 590-592 | Chemical | denotes | 1H | |
1106 | 688-696 | Chemical | denotes | hydrogen | MESH:D006859 |
1107 | 834-850 | Chemical | denotes | naphthoate ester | |
1108 | 917-926 | Chemical | denotes | ketorolac | MESH:D020910 |
1109 | 927-930 | Chemical | denotes | ANS | MESH:C027132 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T664 | 0-6 | Sentence | denotes | 3.6.8. |
T665 | 7-12 | Sentence | denotes | HECSP |
T666 | 13-130 | Sentence | denotes | In silico methods combined with NMR derived information can also be used to determine accurate drug-target complexes. |
T667 | 131-266 | Sentence | denotes | 1H empirical chemical shift perturbation (HECSP) is an empirical model that is based on chemical shift perturbation (CSP) of a protein. |
T668 | 267-410 | Sentence | denotes | CSP represents the change in chemical shifts in a protein due to alteration of its chemical environment (which can happen upon ligand binding). |
T669 | 411-570 | Sentence | denotes | The CSP of a target protein is obtained by a series of 2D HSQC experiments with a set of ligand titrations involving samples that contain 15N-labelled protein. |
T670 | 571-648 | Sentence | denotes | The calculation of 1H-CSPs inside the protein are based on four contributors: |
T671 | 649-738 | Sentence | denotes | 1) ring current, 2) electric field, 3) hydrogen bonding, and last 4) magnetic anisotropy. |
T672 | 739-939 | Sentence | denotes | To show the value of the HECSP model two CSP examples were used: apo-neocarzinostatin (apoNCS)-naphthoate ester complex, and human intestinal fatty acid binding protein (hIFABP)-ketorolac-ANS complex. |
T673 | 940-1131 | Sentence | denotes | The results from the experiment showed that HECSP model can distinguish native ligand from decoys and more clearly define protein-ligand complex structures with NMR derived information [407]. |